Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo


Get News and Updates



CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn


New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

Molecular Saliva Test Detects Oral Cancer, Diabetes

2012_11_20_14_52_15_961_Neil_Gottehrer_175November 28, 2012 — A Pennsylvania start-up is gearing up to launch a molecular saliva test that analyzes biomarkers to detect oral cancer and diabetes. PeriRx is now conducting clinical trials of its diagnostic test, which has attracted the interest of the U.K.’s National Institute for Health Research.

The genesis for the test came from a collaboration between Neil Gottehrer, DDS, a Havertown, PA, dentist who has been practicing for 38 years, and David T.W. Wong, DMD, DMSc, a pioneer in salivary diagnostics who is the associate dean of research and a professor of oral biology at the University of California, Los Angeles (UCLA) School of Dentistry. [Read more…]